AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$8.56 USD
-0.30 (-3.39%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $8.56 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ANGO 8.56 -0.30(-3.39%)
Will ANGO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ANGO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANGO
ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
ANGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System
Reasons to Retain TransMedics Stock in Your Portfolio for Now
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Other News for ANGO
AngioDynamics (ANGO) Initiates Study on Auryon Atherectomy System
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb ...
AngioDynamics enrolls first patient in Auryon Atherectomy combination study
AngioDynamics (ANGO) Reports Positive Results from PRESERVE Study | ANGO Stock News
AngioDynamics meets primary endpoint in PRESERVE study